- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Sara Brinkmann
Events 8 results
Conference
March 17, 2025
34th Annual King & Spalding Health Law & Policy Forum
Webinar
January 28, 2025
Overpayments, Internal Investigations and FCA Updates: What Providers Need to Know for Continued Compliance in 2025
Speaking Engagement
January 14, 2025
Sara Brinkmann and Lauren Gennett to Speak at Health Care Compliance Association and Society of Corporate Compliance and Ethics podcast
Speaking Engagement
November 17, 2024
Sara Brinkmann to Speak at the American Health Law Association’s Fundamentals of Health Law Conference
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
November 5, 2023
Sara Brinkmann to Speak at American Health Law Association’s Fundamentals of Health Law Conference
Webinar
February 15, 2023
Healthcare Fraud Enforcement Update - What Does 2023 Hold?
Speaking Engagement
November 9, 2022
Sara Brinkmann to Speak at American Health Law Association’s Fundamentals of Health Law Conference